No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response


  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Δοκιμάζετε άλλον τρόπο να εξηγήσετε την άσκηση που πιστεύετε ότι θα βοηθήσει
  • To ensure proper folding and function of the restriction endonuclease, maximizing its catalytic activity
  • To stabilize the DNA double helix structure, ensuring precise cleavage
  • EcoRI
  • Xanthoproteic test
  • Access cardiac function.
  • No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up